|
There are more than 20 types of insulin sold in the US today. Insulin is classified by:
|
As individuals differs in
their response to insulin, the onset, peak time, and duration of various insulin
preparations are given as ranges. Insulin available in the U.S. is obtained
either directly from pork pancreas or from chemical modification of pork insulin.
It is also made chemically identical to human insulin by recombinant DNA technology.
Human insulin manufactured using recombinant DNA technology is replacing pork
insulin. Beef insulin differs from human insulin at 3 amino acid sites and pork
insulin differs at one site. As a result, beef insulin causes more allergic
reactions than pork insulin, and is not available in the U.S.
Different types and species
of insulin have different pharmacological properties. Human insulin is recommended
for pregnant women, women considering pregnancy, people with allergies or immune
resistance to animal-derived insulins, and people beginning insulin therapy.
Changing insulin species may affect blood glucose control and should only be
done under the supervision of a health professional with expertise in diabetes
management. If a patient is admitted to the hospital, the type of insulin he
or she has been using should not be changed indiscriminately. In all instances
of insulin use, dosages must be individualized and balanced with medical nutrition
therapy and exercise.
Instant Feedback:
Short acting or regular
insulin usually reaches the blood within 30 minutes after injection, peaks in
2 to 4 hours and stays in the bloodstream for 6 to 8 hours. Intermediate acting
(NPH and lente) insulins reach the bloodstream 2 to 4 hours after
injection. They peak within 6 to 8 hours and stay in the bloodstream for 16
to 20 hours. Long acting (ultralente) insulin takes 6 to 8 hours to reach
the bloodstream. It has no peak or a very small peak 10 to 16 hours after injection.
It stays in the bloodstream 24 hours or longer.
The human insulin ultralente
and the synthetic human insulin glargine are long acting insulins. Glargine
is given once a day at bedtime. With a timing profile of about 24 hours and
no pronounced peak effect, glargine provides basal insulin coverage over an
entire day and night.
Different companies
have adopted different names for the same short, intermediate, or long action
types of insulin or their mixtures. Combinations of insulins, such as Humulin
® 70/30 or Novolin ® 70/30 are also available. This chart shows some
common trade names for various insulin preparations.
| Rapid acting insulins | Human insulin analogues - Humalog ® lispro and Novolog ® aspart |
| Short acting ("Regular") insulins |
Human sources - Humulin ® R regular, Novolin ® R regular, and Velosulin ® BR regular Pork sources - Iletin II ® regular and Purified Pork regular |
| Intermediate acting insulins |
Human sources - Humulin ® L (Lente), Humulin ® N (NPH), Novolin ® L (Lente), and Novolin ® (NPH) Pork sources - Iletin ® II, Iletin II ® NPH, Purified Pork Lente and Purified NPH |
| Long-acting insulins |
Human source Humulin ® U (Ultralente) Human insulin analogue Lantus ® (insulin glargine) |
| Source: Pharmacologic therapies. (2001). Diabetes Management Therapies: A Core Curriculum for Diabetes Education (4th Ed.) American Association of Diabetes Educators, p. 95. | |
Because of its short and predictable peak action, regular insulin is the insulin product routinely used for intravenous administration.
Insulin concentrations
currently available in the U.S. are U-100 and U-500, indicating 100 units or
500 units per milliliter. U-500 is only used in rare cases of insulin resistance
when the patient requires extremely large doses. Travelers should be aware that
insulin is available in a U-40 strength outside the U.S. To avoid dosing errors,
syringes that match the concentration of U-40 insulin must be used.
Instant Feedback:
©2009 RnCeus.com